Deep in Biological Technology

A Swiss Team Uses Transcranial MR-Guided Focused Ultrasound to Treat Patients With Functional Brain Disorders

... pain successfully underwent non-invasive deep brain ablation surgery (central lateral ... to duplicate the therapeutic effects of invasive deep brain ablation without the side effects for a ... and effective way to non-invasively ablate tissue deep within the brain," said Ernst Martin, M.D., ...

Photos: FDA Approves 12-Month Labeling Update for EVOLENCE(R) Collagen-Based Facial Filler

... dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial ... of EVOLENCE(R) for treatment of moderate to deep facial wrinkles through one year(1). EVOLENCE(R) ... provides long-lasting treatment of moderate to deep facial wrinkles and folds, such as nasolabial ...

Global Financial Crisis Making Biotech Business Model Unsustainable, According to Ernst & Young

... deep financing challenges separate haves and have-nots ... prior funding droughts, this crisis is systemic, deep and protracted. To thrive in this environment, ... to help you achieve your potential - a team with deep technical experience in providing assurance, tax, ...

Real Time Genomics to Show SLIM Search(TM) Technology on Windows HPC Server 2008 at Bio-IT World Conference

... Introducing deep Genomic Analysis SAN FRANCISCO, April 27 ... Real Time Genomics will demonstrate solutions for deep genomic analysis at Bio-IT World Conference 2009 ... give genomic researchers the ability to perform deep genomic analysis, in real time, while also ...

Venter Institute Launches the J. Robert Beyster and Life Technologies 2009-2010 Research Voyage of the Sorcerer II Expedition

... team after the organism was isolated from a deep sea vent in the Pacific. After a successful ... Several JCVI researchers also participated in deep sea sampling cruises as part of expeditions onboard the R/V Atlantis which carries the deep sea submersible, Alvin. JCVI scientists also ...

The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment

... risks. DVT is a blood clot that forms inside a deep vein, most often in the lower leg. Once formed, a ... DVT is a blood clot that forms inside a deep vein, most often in the lower leg. Once formed, a ... at: Public Health Leadership Conference on deep Vein Thrombosis; February 26, 2003: Washington, ....

ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis

... anticoagulant TB-402 for the prophylaxis of deep Vein Thrombosis (DVT) following orthopaedic ... in a number of clinical settings." About deep Vein Thrombosis (DVT) DVT is caused when a blood clot forms in a deep vein, most commonly ...

90 billion tons of microbial organisms live in the deep biosphere

... in terms of carbon massliving in the deep biosphere, in a research article published online ... (JAMSTEC) concluded that about 87 percent of the deep biosphere consists of Archaea. This finding is in ... investigations have proven the existence of the deep biosphere. "In general, life below the ...

Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy

... - Ablative Solution to Treat deep Wrinkles and Significant Photo Damage - ... "Affirm CO2 is a dynamic platform to address deep wrinkles, significant photoaging, severe scar ... the most effective treatment option for deep wrinkles. The result is a system that helps ...

Satyam Forms Partnership with Sciformix to Provide Comprehensive Drug Safety Management

... very pleased by this partnership. Sciformix has deep expertise delivering end-to-end safety management ... life sciences industry, along with Sciformix's deep domain expertise, offer global ... industries and 63* countries. Satyam leverages deep industry and functional expertise, ...

First Patient Enrolled in SONIC I Registry of OmniSonics Medical Technologies' OmniWave(TM) Endovascular System

... percutaneous mechanical thrombectomy of acute deep vein thrombosis (DVT). All patients enrolled ... pharmacological and mechanical treatments for deep vein thrombosis (DVT)." In response to this ... clot) occurs in a number of conditions including deep vein thrombosis (DVT) and acute limb ischemia. ...

Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa)

... Perisurgery: PROCRIT(R) increased the rate of deep venous thromboses in patients not receiving prophylactic anticoagulation. Consider deep venous thrombosis prophylaxis. (See WARNINGS: ... Perisurgery: PROCRIT(R) increased the rate of deep venous thromboses in patients not receiving ...

Clexane(R)/Lovenox(R) Approved in Japan

... hospitalized for orthopaedic surgery. deep vein thrombosis (DVT) and pulmonary embolism are ... of orthopaedic surgery patients may suffer from deep vein thrombosis. Among the hospitalised patients ... . 5. Coalition to Prevent deep Vein Thrombosis. Available at ...

Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) Label Reflects Recommendations from Recent FDA Advisory Committee Meetings

... Perisurgery: PROCRIT(R) increased the rate of deep venous thromboses in patients not receiving prophylactic anticoagulation. Consider deep venous thrombosis prophylaxis. (See WARNINGS: ... Perisurgery: PROCRIT increased the rate of deep venous thromboses in patients not receiving ...

ThromboGenics - Business Update and Interim Results for the Seven Month Period Ending 30 June 2007

... for the treatment and prevention of deep vein thrombosis (DVT) and atrial fibrillation. ... intra-arterial and intravenous application), deep vein thrombosis and in acute peripheral arterial ... for the treatment and prevention of deep vein thrombosis (DVT) and atrial fibrillation. A ...

Amgen to Collaborate With GlaxoSmithKline to Commercialize Denosumab in Europe for Postmenopausal Osteoporosis (PMO)

... program is the largest ever initiated by Amgen. This broad and deep development program demonstrates Amgen's commitment to researching and ... kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to ...

Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting

... Perisurgery: PROCRIT (Epoetin alfa) increased the rate of deep venous thromboses in patients not receiving prophylactic anticoagulation. Consider deep venous thrombosis prophylaxis. Contraindications ...

Event Alert: 'SPL R4 Compliance and its Impact on Regulatory Submission Processes'

... With 20+ years in the drug and medical device industries, Tadikonda has a deep understanding of drug discovery and development processes, significant ... software products, combined with comprehensive professional services and deep domain expertise enhance quality and compliance for some of the world's ...

Lycera Closes $36 Million Series A Financing

... and general partners in Menlo Park, CA, and Dallas, TX, who bring together deep domain knowledge in life sciences and information technology. Visit ... investing in biopharmaceuticals and medical technology companies with the deep and diverse expertise of the team in research and development, ...

Paul Keim Appointed to febit's Scientific Advisory Board

... Paul Keim brings deep knowledge in the field of medical microbiology, biodefense and pathogens ... medical microbiology, biosecurity and the genomics of pathogens he brings deep knowledge from these fields to febit. Dr. Keim's expertise will be ...

The MedZilla Report: Febraury 2009 Employment Outlook for Biotech/Pharma/Health

... of layoffs in health care in January, the industry seems to have taken a deep breath and a step back, getting back on track and creating 27,000 new ... worst is past for health care, it does seem as though the industry took a deep breath and a step back in February, getting back on track after January's ...

Automated Sequence Capture for Next-Generation Sequencing Paves the Way for Personalized Medicine

... over the past months, HybSelect demonstrated superb enrichment factors and deep sequencing coverage for a broad range of human genes and genomic regions. ... Nevertheless, conducting statistically relevant biomedical studies with deep sequencing of patient samples is still prohibitively expensive and ...

Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets

... them to establish a long history of success in creating value. Their deep relationships with world thought leaders and decision makers allow this ... investing in biopharmaceuticals and medical technology companies with the deep and diverse expertise of the team in research and ...

Clarus Ventures Names Two New Partners

... them to establish a long history of success in creating value. Their deep relationships with world thought leaders and decision makers allow this ... investing in biopharmaceuticals and medical technology companies with the deep and diverse expertise of the team in research and development, ...

OncoGenex Pharmaceuticals announces out-license of TOCOSOL Paclitaxel to Eagle Pharmaceuticals

... including out-licensing. "We intend to focus all of our efforts on the deep pipeline we currently have in development, including OGX-011 which is ... that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism ...

Genstruct and Sirtris Pharmaceuticals Win Bio-IT World's Best Practices Award

... CEO at Genstruct. "Using our CNM platform, we were able to help develop a deep understanding of the SIRT1 pathway and allowed Sirtris to efficiently ... the components within the whole biological system, Genstruct delivers a deep molecular understanding of diseases and drug action, as well as ...

Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership

... We are pleased to be working with an organization that also values our deep commitment to being a 'solution provider' for our clients." "Premier ... process. We leverage the power of electronic submissions through deep domain knowledge, cross-functional electronic submission expertise, a ...

Quest PharmaTech Receives Support from National Research Council's Industrial Research Assistance Program (NRC-IRAP) to develop Ultrasound Technology for the Treatment of Cancer

... administration of non-toxic pharmaceutical agents which may be activated deep within the body, by ultrasound, which is in itself non-toxic. The ... from the ability to focus the ultrasound energy on malignancy sites buried deep in tissues and to locally activate a preloaded sonosensitizer. The goal of ...

Device That Clears Debris From Artery Aids Blood Flow in PCI

... to occlude the tiny vessels, or microcirculation, that supply blood deep into the heart muscle. When this happens -- even if the surface artery has ... A myocardial blush grade of 3 indicates that x-ray dye has reached deep into the heart muscle, a sign of good blood flow through the ...

Alexza Completes $10 Million Equity Financing with Bio*One Capital to Initiate Commercial Manufacturing in Singapore

... offer patients a new paradigm to rapid systemic drug delivery through deep lung inhalation. We believe that combining Alexza's unique technology and ... a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into ...

Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents

... of a chemotherapy course. Perisurgery: PROCRIT increased the rate of deep venous thromboses in patients not receiving prophylactic anticoagulation. Consider deep venous thrombosis prophylaxis. Contraindications PROCRIT is ...

Clarus Ventures Closes $660 Million Fund

... and Kurt Wheeler, an established group of investment professionals with deep and complementary backgrounds within the life sciences industry. The ... expertise of investing in biopharmaceuticals and medical technology with deep and diverse expertise in research and development, commercialization, ...

Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)

... inhaler designed to generate and deliver excipient-free drug aerosol for deep lung delivery that results in IV-like pharmacokinetics. Alexza has ... a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the ...

Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Company's Board of Directors

... as a Board member will allow us to continue to benefit from his deep knowledge of our organization, technology platforms and development ... with its leading PEGylation and Pulmonary technology platforms and a deep pipeline of innovative and promising therapeutics in development. I am ...

The LANCET Published ENDORSE, the Largest Multinational Study Showing That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE Prophylaxis

... among patients hospitalized for acute medical and surgical illnesses. deep vein thrombosis (DVT) and pulmonary embolism are common manifestations of ... development. Established in 1994, COR is an outgrowth of the Worcester deep Vein Thrombosis Study, a five-year NIH-supported program, which ...

Alexza Announces Partnership With Endo for AZ-003 (Staccato(R) fentanyl) in North America

... designed to generate and deliver excipient-free fentanyl aerosol for deep lung delivery. The current product candidate consists of a disposable dose ... a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into ...

Prix Galien USA Announces 2009 Final Candidates

... 7 /PRNewswire-USNewswire/ -- The 2009 Prix Galien USA will recognize innovative biopharmaceutical drugs and medical technologies that have made a deep impact on the quality of human life at a gala event on September 30. Candidates for the 2009 program provide relief to millions of people living with ...

OncoGenex Reports Second Quarter 2009 Financial Results

... company committed to the development and commercialization of new therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug ...

iCardiac Expands Sales and Marketing Team

... laboratories. "We are excited to welcome Susan to the iCardiac team," said Sasha Latypova, Executive Vice President. "Susan's deep client relationships and long history of successfully partnering with clinical pharmacology units will allow iCardiac to better serve its rapidly ...

NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development

... Drug Administration and the Ministry of Health Labor and Welfare (MHLW) in Japan. Among the many strengths Wu adds to NovaBay's executive team is his deep understanding of Good Clinical Practice (GCP) guidelines and of the International Conference on Harmonization of Technical Requirements for ...